Promise and problems of translational research

被引：1
|
作者：
Benbrook, Doris M.
Karlan, Beth Y.
机构：
[1] Univ Oklahoma, Hlth Sci Ctr, Dept Obstet & Gynecol, Oklahoma City, OK 73190 USA
[2] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA
[3] Cedars Sinai Med Ctr, CSMC Burns & Allen Res Inst, Samuel Oschin Comprehens Canc Inst, Womens Canc Res Inst, Los Angeles, CA 90048 USA
[4] Cedars Sinai Med Ctr, CSMC Burns & Allen Res Inst, Div Gynecol Oncol, Los Angeles, CA 90048 USA
来源：
GYNECOLOGIC ONCOLOGY | 2006年 / 103卷 / 02期
关键词：
D O I：
10.1016/j.ygyno.2006.08.019
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The potential for synergistic collaboration to increase progress in the state of the science for ovarian cancer is provided by services and programs developed and supported by National Cancer Institute (NCI), the Gynecologic Oncology Group (GOG) and the Specialized Programs of Research Excellence (SPOREs). The capabilities span from drug discovery to phase III clinical trials, all of which are available for collaborative interaction with each other and with individual researchers.
引用
收藏
页码：S14 / S17
页数：4
相关论文
共 50 条
12345